161 – 170 of 369
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Oncologic and functional outcomes 1 year after radical prostatectomy for very low risk prostate cancer. Results from the prospective LAPPRO trial.
- Contribution to journal › Article
-
Mark
Low β2-adrenergic receptor level may promote development of castration resistant prostate cancer and altered steroid metabolism.
- Contribution to journal › Article
-
Mark
The Proteome of Primary Prostate Cancer.
- Contribution to journal › Article
-
Mark
Bone Scan Index as an Imaging Biomarker in Metastatic Castration-resistant Prostate Cancer : A Multicentre Study Based on Patients Treated with Abiraterone Acetate (Zytiga) in Clinical Practice
- Contribution to journal › Article
-
Mark
Bone Scan Index and Progression-free Survival Data for Progressive Metastatic Castration-resistant Prostate Cancer Patients Who Received ODM-201 in the ARADES Multicentre Study
- Contribution to journal › Article
-
Mark
Validation of novel biomarkers for prostate cancer progression by the combination of bioinformatics, clinical and functional studies
- Contribution to journal › Article
-
Mark
PBX3 is a putative biomarker of aggressive prostate cancer
- Contribution to journal › Article
-
Mark
Prediction of clinical progression after radical prostatectomy in a nationwide population-based cohort
- Contribution to journal › Article
-
Mark
Making Predictive Biomarkers Readily Available
- Contribution to journal › Debate/Note/Editorial
-
Mark
Quantitative Time-Resolved Fluorescence Imaging of Androgen Receptor and Prostate-Specific Antigen in Prostate Tissue Sections
- Contribution to journal › Article
